Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT)
Neoplasms, Second Primary
Longer follow-up is required to determine how the risk of SMN after IMRT compares to other modalities of radiation treatment, such as proton therapy. This study provides a preliminary report, which will serve as a baseline for future longitudinal analyses of SMN risk after IMRT. Pediatr Blood Cancer 2015;62:311-316. © 2014 Wiley Periodicals, Inc.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency